DAA treatment for hepatitis C among people who inject drugs

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.

Episode metadata supplied by the publisher feed · Published Oct 25, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

DAA treatment for hepatitis C among people who inject drugs

0:00 11:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 11 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on October 25, 2018.

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!